Oliver Kurzai

National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 3641 532-1347 oliver.kurzai@leibniz-hki.de

Curriculum vitae

Main Research Areas

Infection biology of human pathogenic fungi (especially Candida albicans)
Infection biology of Neisseria meningitidis

Professional Career

Since 2017	Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena
2009-2016	Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena
2008	Habilitation in medical microbiology, University Würzburg
2006	Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer)
2003	Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg
2001-2002	Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg
2002	Dr. med., “summa cum laude” University Würzburg
2001	Staatsexamen (state examination) in human medicine, University Würzburg

Awards · Appointments · Scientific Activities

Since 2014	Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk)
Since 2013	Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena
Since 2012	Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage)
Since 2012	Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM)
Since 2011	Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG
2015-2016	Speaker of the ZIK Septomics
2011-2013	Editor, Journal of Basic Microbiology
2009	Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG)
2008	Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie
2003	Science award from the Unterfränkische Gedenkjahrstiftung
2003	Dissertation award from the medical faculty of the University Würzburg
2002	Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie

Publications

Papan C, Geipel M, Heidtmann S, Müller R, Praschmo D, Meier CM, Walther G, Kurzai O, Groll AH, Zemlin M, Simon A (2023) A mould in the fold should never grow old: cutaneous aspergillosis in a preterm neonate. Clin Microbiol Infect 29(3), 338-339.

Details

Reusch J, Wagenhäuser I, Gabel A, Eggestein A, Höhn A, Lâm TT, Frey A, Schubert-Unkmeir A, Dölken L, Frantz S, Kurzai O, Vogel U, Krone M, Petri N (2023) Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study. J Med Virol 95(1), e28300.

Details

Reusch J, Wagenhäuser I, Gabel A, Höhn A, Lâm TT, Krone LB, Frey A, Schubert-Unkmeir A, Dölken L, Frantz S, Kurzai O, Vogel U, Krone M, Petri N (2023) Inability to work following COVID-19 vaccination-a relevant aspect for future booster vaccinations. Public Health 222, 186-195.

Details

Sartawi Z, Blackshields C, Ariamanesh A, Farag FF, Griffin B, Crean A, Devine K, Elkhashab M, Aldejohann AM, Kurzai O, Faisal W (2023) Glass microneedles: A case sudy for regulatory approval using a quality by design approach. Adv Mater 35(52), e2305834.

Details

Wagenhäuser I, Knies K, Hofmann D, Rauschenberger V, Eisenmann M, Reusch J, Gabel A, Flemming S, Andres O, Petri N, Topp MS, Papsdorf M, McDonogh M, Verma-Führing R, Scherzad A, Zeller D, Böhm H, Gesierich A, Seitz AK, Kiderlen M, Gawlik M, Taurines R, Wurmb T, Ernestus RI, Forster J, Weismann D, Weißbrich B, Dölken L, Liese J, Kaderali L, Kurzai O, Vogel U, Krone M (2023) Virus variant-specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022. Clin Microbiol Infect 29(2), 225-232.

Details

Wagenhäuser I, Mees J, Reusch J, Lâm TT, Schubert-Unkmeir A, Krone LB, Frey A, Kurzai O, Frantz S, Dölken L, Liese J, Gabel A, Petri N, Krone M (2023) Determinants of Influenza A infection rate in post-COVID-19 era. J Infect 87(4), 361-364.

Details

Wagenhäuser I, Reusch J, Gabel A, Höhn A, Lâm TT, Almanzar G, Prelog M, Krone LB, Frey A, Schubert-Unkmeir A, Dölken L, Frantz S, Kurzai O, Vogel U, Petri N, Krone M (2023) Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination. Eur Respir J 61(1), 2201390.

Details

Wagenhäuser I, Reusch J, Gabel A, Krone LB, Kurzai O, Petri N, Krone M (2023) Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster. Clin Microbiol Infect 29(4), 554-556.

Details

Wagenhäuser I, Reusch J, Gabel A, Mees J, Nyawale H, Frey A, Lâm TT, Schubert-Unkmeir A, Dölken L, Kurzai O, Frantz S, Petri N, Krone M, Krone LB (2023) The relationship between mental health, sleep quality and the immunogenicity of COVID-19 vaccinations. J Sleep Res 33(3), e13929.

Details

Weiß M, Gründahl M, Deckert J, Eichner FA, Kohls M, Störk S, Heuschmann PU, Hein G (2023) Differential network interactions between psychosocial factors, mental health, and health-related quality of life in women and men. Sci Rep 13(1), 11642.

Details